Ingrid Delaet insider trades

Open-market stock purchases and sales by Ingrid Delaet, Chief Regulatory Officer at Neurocrine Biosciences Inc, from SEC Form 4 filings since Feb 13, 2023.

Recent trades

DateStockTradeValue
Sep 11, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Sep 11, 2026NBIX Neurocrine Biosciences IncSold (not open market)$378K
Jul 10, 2026NBIX Neurocrine Biosciences IncSold$791K
Jul 10, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jul 9, 2026NBIX Neurocrine Biosciences IncSold$1.5M
Jul 9, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jul 8, 2026NBIX Neurocrine Biosciences IncSold$489K
Jul 8, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jul 7, 2026NBIX Neurocrine Biosciences IncSold$607K
Jul 7, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 29, 2026NBIX Neurocrine Biosciences IncSold$354K
May 29, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$91.1K
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$1.3M
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 13, 2026NBIX Neurocrine Biosciences IncSold (not open market)$93.8K
Feb 13, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Feb 12, 2026NBIX Neurocrine Biosciences IncSold (not open market)$108K
Feb 12, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
Jan 31, 2026NBIX Neurocrine Biosciences IncSold (not open market)$64.6K
Jan 31, 2026NBIX Neurocrine Biosciences IncBought (not open market)—

Companies traded

  • NBIX Neurocrine Biosciences Inc: 34 sales, last Sep 11, 2026

Get free alerts when Ingrid Delaet files a new trade →